Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tonipharm is a French pharmaceutical company founded in 1991 that specializes in the development and distribution of over-the-counter (OTC) and prescription medications. The company is widely recognized for its flagship brand, Ginkor Fort, which is a market leader in France for the treatment of venous insufficiency and hemorrhoidal symptoms. In 2018, Tonipharm was acquired by the Mayoly Spindler Group (now Mayoly), a move that integrated Tonipharm's strong consumer healthcare portfolio into Mayoly's broader international operations. Beyond venous health, the company offers oral hygiene solutions under the Alodont brand and cognitive support supplements. Tonipharm maintains a significant presence in the French pharmacy retail market while benefiting from the global reach of its parent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tonipharm Laboratory.